Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine
暂无分享,去创建一个
S Glasauer | T. Brandt | S. Glasauer | M. Dichgans | M. Strupp | R. Kalla | T. Freilinger | R Kalla | M Strupp | T Brandt | M Dichgans | T Freilinger
[1] Yoram Grossman,et al. Highly 4-aminopyridine sensitive delayed rectifier current modulates the excitability of guinea pig cerebellar Purkinje cells , 2001, Experimental Brain Research.
[2] R. Keynes. The ionic channels in excitable membranes. , 1975, Ciba Foundation symposium.
[3] U Büttner,et al. Treatment of downbeat nystagmus with 3,4-diaminopyridine , 2003, Neurology.
[4] Dimitri M Kullmann,et al. The neuronal channelopathies. , 2002, Brain : a journal of neurology.
[5] R. Baloh,et al. Clinical spectrum of episodic ataxia type 2 , 2004, Neurology.
[6] J G Nutt,et al. Episodic ataxias as channelopathies , 1995, Annals of neurology.
[7] B. Trainor,et al. Arginine Vasotocin Interacts with the Social Environment to Regulate Advertisement Calling in the Gray Treefrog (Hyla versicolor) , 2003, Brain, Behavior and Evolution.
[8] Dennis E Bulman,et al. Familial Hemiplegic Migraine and Episodic Ataxia Type-2 Are Caused by Mutations in the Ca2+ Channel Gene CACNL1A4 , 1996, Cell.
[9] Y. Hayashi,et al. A family of episodic ataxia type 2: no evidence of genetic linkage to the CACNA1A gene. , 2003, International journal of molecular medicine.
[10] Michael G Hanna,et al. Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel , 2001, The Lancet.
[11] Robert C. Griggs,et al. Hereditary paroxysmal ataxia , 1978, Neurology.